Psyence Biomedical (PBM) Balance Sheet: Assets & Liabilities

Psyence Biomedical (PBM) Balance Sheet

As of Mar 31, 2026 (end of fiscal 2026), Psyence Biomedical reported total assets of $17.57M and total liabilities of $623.19K. Shareholders' equity was $16.94M, up 152.1% from $6.72M a year earlier. Total debt stood at $0.00 against $7.44M in cash and short-term investments, a net cash position of $7.44M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

Psyence Biomedical Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Psyence Biomedical Ltd. (PBM) - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period ending	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Current Assets
Cash and Cash Equivalents	7.44	6.14	0.73	0.02	0.43
Cash & Short-Term Investments	7.44	6.14	0.73	0.02	0.43
Accounts Receivable	0.36	0.14	0.04	0.06	0.04
Inventory	0.00	0.00	0.00	0.00	-0.04
Other Current Assets	1.30	0.29	0.35	1.13	0.37
Total Current Assets	9.11	6.56	1.13	1.21	0.80
Non-Current Assets
Property, Plant & Equipment (Net)	0.01	0.01	0.01	0.00	0.00
Long-Term Investments	8.06	0.75	0.00	257.73	255.00
Other Non-Current Assets	0.39	0.00	0.00	0.00	0.25
Total Non-Current Assets	8.46	0.76	0.01	257.73	255.25
Total Assets	17.57	7.32	1.13	258.93	326.55
Current Liabilities
Accounts Payable	0.41	0.26	3.55	1.63	0.04
Short-Term Debt	0.00	0.00	7.66	0.69	0.00
Accrued Liabilities	0.08	0.05	0.13	0.16	0.09
Other Current Liabilities	0.22	0.33	0.90	11.96	0.11
Total Current Liabilities	0.62	0.59	12.10	14.27	0.14
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	16.24
Total Non-Current Liabilities	0.00	0.00	0.00	0.00	16.24
Total Liabilities	0.62	0.59	12.10	14.27	16.38
Stockholders' Equity
Common Stock	78.75	61.75	46.13	258.55	255.00
Retained Earnings	-63.38	-56.45	-57.46	-13.90	-18.36
Accumulated Other Comprehensive Income	0.40	0.35	0.36	0.00	0.00
Additional Paid-in Capital	1.18	1.07	0.00	0.00	0.00
Shares Outstanding	2.29	0.09	0.00	0.00	0.00
Total Stockholders' Equity	16.94	6.72	-10.97	244.66	236.65
Total Liabilities & Equity	17.57	7.32	1.13	258.93	256.22

Source: Company financial statements from annual and quarterly filings. Data as of Mar 31, 2026. Data sources and methodology

Frequently Asked Questions About Psyence Biomedical Balance Sheet

How much debt does Psyence Biomedical have?

Psyence Biomedical had total debt of $0.00 as of Mar 31, 2026, against $7.44M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $0.00 a year earlier.

What are Psyence Biomedical's total assets?

Psyence Biomedical reported total assets of $17.57M as of Mar 31, 2026, up 140.1% from $7.32M a year earlier. Total liabilities were $623.19K.

What is Psyence Biomedical's shareholders' equity?

Psyence Biomedical's shareholders' equity was $16.94M as of Mar 31, 2026, or about $7.39 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition